Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-30

Clinical Trial Update: To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy

View source ↗

Summary

A clinical trial is evaluating the efficacy of alirocumab compared with standard statin therapy for treating neoatherosclerosis in the coronary arteries. Outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • alirocumab (alirocumab)

Snippet

Sponsor: Kobe University | Conditions: Coronary Artery Disease Progression | Status: UNKNOWN